4
Changes in Ownership
PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-23-019523
Chief Commercial Officer sold 12,103 shares at $3.31 ($40,075)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ludwig Jeffrey Jerome Chief Commercial Officer | 2023-07-03 | Sale 10b5-1 | −12,103 | $3.31 | $40,075 | 112,926 | D |
| Open-market sales · 12,103 sh · avg $3.31 · $40,075 | |||||||
Loading xslF345X04/rdgdoc.xml…